Evidence map›Paper›PMID 29358368›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Antibody detection by agglutination-PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis.

Cheng-Ting Tsai, Peter V Robinson, Felipe de Jesus Cortez, Maria L B Elma, David Seftel, Narges Pourmandi, Mark W Pandori, Carolyn R Bertozzi

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Early diagnosis of HIV/aids infection: concept analysis.Revista brasileira de enfermagem · 2023
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Detection of SARS-CoV-2 neutralizing antibodies with a cell-free PCR assay.medRxiv : the preprint server for health sciences · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Cheng-Ting TsaiDepartment of Chemistry, Stanford University, Stanford, CA 94305.
Peter V RobinsonEnable Biosciences, San Francisco, CA 94107.
Felipe de Jesus CortezEnable Biosciences, San Francisco, CA 94107.
Maria L B ElmaAlameda County Public Health Laboratory, Oakland, CA 94605.
David SeftelEnable Biosciences, San Francisco, CA 94107.
Narges PourmandiEnable Biosciences, San Francisco, CA 94107.
Mark W PandoriAlameda County Public Health Laboratory, Oakland, CA 94605; Mark.Pandori@acgov.org bertozzi@stanford.edu.
Carolyn R BertozziDepartment of Chemistry, Stanford University, Stanford, CA 94305; Mark.Pandori@acgov.org bertozzi@stanford.edu.
Alameda County Public Health Department · USHoward Hughes Medical Institute · USStanford University · US

Funding

Revolutionizing the detection of O-GlcNAcR21DK108781 · NIDDK · STANFORD UNIVERSITY · PI BERTOZZI, CAROLYN · 2015 to 2016
$610k
Howard Hughes Medical InstituteNIDDK NIH HHS R21 DK108781
6 · The paper itself

Abstract

Oral fluid (OF) is a highly effective substrate for population-based HIV screening efforts, as it is noninfectious and significantly easier to collect than blood. However, anti-HIV antibodies are found at far lower concentrations in OF compared with blood, leading to poor sensitivity and a longer period of time from infection to detection threshold. Thus, despite its inherent advantages in sample collection, OF is not widely used for population screening. Here we report the development of an HIV OF assay based on Antibody Detection by Agglutination-PCR (ADAP) technology. This assay is 1,000-10,000 times more analytically sensitive than clinical enzyme-linked immunoassays (EIAs), displaying both 100% clinical sensitivity and 100% specificity for detecting HIV antibodies within OF samples. We show that the enhanced analytical sensitivity enables this assay to correctly identify HIV-infected individuals otherwise missed by current OF assays. We envision that the attributes of this improved HIV OF assay can increase testing rates of at-risk individuals while enabling diagnosis and treatment at an earlier time point.

Indexed as

AgglutinationDNAEarly DiagnosisHIV AntibodiesHIV Core Protein p24HIV Envelope Protein gp120HIV Envelope Protein gp41HIV InfectionsHumansMass ScreeningPolymerase Chain ReactionSalivaSensitivity and SpecificityWorkflowDNAgp120 protein, Human immunodeficiency virus 1HIV AntibodiesHIV Core Protein p24HIV Envelope Protein gp120HIV Envelope Protein gp41immunoassayinfection diseasesoral fluidPCRprotein–DNA conjugation

Identifiers

PMID29358368
PMCPMC5819393
OpenAlexW2785218589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.